DJO Reports 3Q18 Revenue of $294.1MM, +1.1% vs. 3Q17

DJO reported revenue of $294.1MM in 3Q18, +1.1% vs. 3Q17, while continuing to make progress on the margin-expansion transformation initiatives undertaken in 2017. ASC 606 adoption impacted the company’s Recovery Sciences and Bracing and Vascular segments by a total $5MM in the quarter. Excluding that impact, growth for 3Q18 was 2.8%. In the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us